Trial intelligence / Profile preview

Periarticular Injection Versus Peripheral Nerve Block in Total Hip Arthroplasty

NCT03977454Phase 2Completed

Sponsor
Yale University
Start
Nov 2019
Primary completion
Jun 2021
Countries
1
01

Overview

Phase 2, randomised trial in hip arthropathy (2 arms), sponsored by Yale University. Primary endpoint: Daily Opioid Consumption at 72 hours. Started Nov 2019; status: completed.

02

Conditions

hip arthropathy

Beyond the preview

Go deeper on NCT03977454.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03977454.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call